BNP Paribas Financial Markets’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-9,214
| Closed | -$736K | – | 4138 |
|
|
2021
Q1 | $736K | Buy |
9,214
+69
| +0.8% | +$5.39K | ﹤0.01% | 2333 |
|
|
2020
Q4 | $721K | Buy |
9,145
+3,347
| +58% | +$196K | ﹤0.01% | 2250 |
|
|
2020
Q3 | $255K | Sell |
5,798
-127,810
| -96% | -$6.3M | ﹤0.01% | 2628 |
|
|
2020
Q2 | $5.91M | Buy |
133,608
+131,634
| +6,668% | +$4.91M | 0.01% | 975 |
|
|
2020
Q1 | $70.9K | Sell |
1,974
-1,645
| -45% | -$93.5K | ﹤0.01% | 3381 |
|
|
2019
Q4 | $257K | Sell |
3,619
-2,332
| -39% | -$169K | ﹤0.01% | 2841 |
|
|
2019
Q3 | $445K | Buy |
5,951
+4,958
| +499% | +$420K | ﹤0.01% | 2277 |
|
|
2019
Q2 | $80.1K | Sell |
993
-285
| -22% | -$20K | ﹤0.01% | 3161 |
|
|
2019
Q1 | $85.5K | Buy |
1,278
+677
| +113% | +$51.3K | ﹤0.01% | 3219 |
|
|
2018
Q4 | $44.7K | Sell |
601
-3,506
| -85% | -$289K | ﹤0.01% | 2765 |
|
|
2018
Q3 | $378K | Buy |
4,107
+435
| +12% | +$41.4K | ﹤0.01% | 2149 |
|
|
2018
Q2 | $361K | Sell |
3,672
-6,486
| -64% | -$725K | ﹤0.01% | 2156 |
|
|
2018
Q1 | $1.13M | Sell |
10,158
-4,756
| -32% | -$533K | ﹤0.01% | 1654 |
|
|
2017
Q4 | $1.53M | Sell |
14,914
-3,844
| -20% | -$383K | ﹤0.01% | 1664 |
|
|
2017
Q3 | $1.77M | Buy |
18,758
+7,055
| +60% | +$557K | ﹤0.01% | 1198 |
|
|
2017
Q2 | $912K | Buy |
11,703
+4,137
| +55% | +$311K | ﹤0.01% | 1590 |
|
|
2017
Q1 | $606K | Buy |
7,566
+830
| +12% | +$66K | ﹤0.01% | 1633 |
|
|
2016
Q4 | $530K | Buy |
6,736
+1,197
| +22% | +$93K | ﹤0.01% | 1672 |
|
|
2016
Q3 | $432K | Sell |
5,539
-5,689
| -51% | -$413K | ﹤0.01% | 1299 |
|
|
2016
Q2 | $772K | Buy |
11,228
+6,050
| +117% | +$417K | ﹤0.01% | 1298 |
|
|
2016
Q1 | $370K | Sell |
5,178
-1,482
| -22% | -$93K | ﹤0.01% | 1294 |
|
|
2015
Q4 | $414K | Sell |
6,660
-386
| -5% | -$23.5K | ﹤0.01% | 1478 |
|
|
2015
Q3 | $400K | Buy |
7,046
+4,188
| +147% | +$222K | ﹤0.01% | 1485 |
|
|
2015
Q2 | $153K | Buy |
2,858
+2,054
| +255% | +$99.9K | ﹤0.01% | 1852 |
|
|
2015
Q1 | $38.2K | Buy |
+804
| New | +$35.6K | ﹤0.01% | 2054 |
|
|
2014
Q4 | – | Sell |
-2,036
| Closed | -$70K | – | 3499 |
|
|
2014
Q3 | $70K | Buy |
2,036
+1,815
| +821% | +$64.1K | ﹤0.01% | 2405 |
|
|
2014
Q2 | $8.09K | Buy |
221
+118
| +115% | +$4K | ﹤0.01% | 2409 |
|
|
2014
Q1 | $3.42K | Sell |
103
-351
| -77% | -$11.6K | ﹤0.01% | 2510 |
|
|
2013
Q4 | $15.4K | Sell |
454
-8,626
| -95% | -$299K | ﹤0.01% | 2375 |
|
|
2013
Q3 | $289K | Sell |
9,080
-2,326
| -20% | -$61.9K | ﹤0.01% | 1953 |
|
|
2013
Q2 | $258K | Buy |
+11,406
| New | +$247K | ﹤0.01% | 2126 |
|
BNP Paribas Financial Markets's CMD Position: Q2 2021 in Review
BNP Paribas Financial Markets sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 9,214 shares — an estimated $736K sold.
BNP Paribas Financial Markets first reported a position in CMD in Q2 2013 and held it in 31 quarters. The position peaked at $5.91M in Q2 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- BNP Paribas Financial Markets reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- BNP Paribas Financial Markets sold 9,214 Cantel Medical Corporation shares in Q2 2021, an estimated $736K.
- BNP Paribas Financial Markets first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 31 quarters.
- BNP Paribas Financial Markets's Cantel Medical Corporation position peaked at $5.91M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.